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Mulberry juice freeze-dried powder attenuates the disease severity by the 
maintaining of colon mucosa in mice with DSS-induced acute colitis 
 
Abstract: This study aimed to evaluate the microbial compositions and gene expression 
related to inflammation in dextran sodium sulfate (DSS)-induced acute colitis and the 
effect of mulberry supplementation. Male BALB/c mice received a diet supplemented 
with mulberry juice freeze-dried powder (MFP) or not for 3 weeks. After 3 weeks, the 
mice received water containing 5% (w/v) DSS or not for 1 week. The disease activity 
index score in mice fed MFP was significantly decreased. A significant decrease in 
Bifidobacterium spp. and the Clostridium perfringens subgroup was observed in mice 
not fed MFP. The number of goblet cell and NLRP6 expression were observed in mice 
fed a diet supplemented with MFP compared with mice not fed MFP. These results may 
indicate that mulberry mitigates DSS-induced acute colitis by a changing the gut 
microbial flora and by improving mucosal conditions. 
 
Keywords: Mulberry, DSS-induced acute colitis, Goblet cell, NLRP6 Inflammasome, 
Microbiota. 
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Introduction 
Cases of inflammatory bowel disease (IBD) are increasing worldwide [1]. The most 
common forms of IBD are ulcerative colitis (UC) and Crohn’s disease (CD). The 
symptoms of IBD include repeated abdominal pain, bloody feces, diarrhea, and fever, 
which together greatly reduce the patients' quality of life [2]. Currently, the underlying 
mechanisms leading to UC and IBD remain unclear while environmental factors have 
been reported to be involved in their disease etiology. The disease pathogenesis widely 
accepted consists of the disruption of the epithelial barrier, triggering an invasion of 
bacteria into the mucosal layer, which then activates the inflammatory immune 
response. The model is useful to study the contribution of innate immune systems in 
intestinal inflammation and presumably due to the toxic effects of dextran sodium 
sulfate (DSS) on epithelial barrier dysfunction. UC development is strongly correlated 
with oxidative stress by reactive oxygen species (ROS) [3]. The inflammatory process 
is accompanied by immunological cell infiltration and the unregulated production of 
proinflammatory cytokines and ROS. High levels of ROS are generated by immune 
cells such as infiltrated active macrophages in the colon, resulting in responses that 
prolong inflammation. Increased levels of proinflammatory cytokines are detected in 
patients with IBD.  
Several families of innate receptors are involved in the recognition of microbe-
associated molecular patterns, such as Toll-like receptors and nucleotide-binding 
oligomerization domain protein-like receptors (NLRs) [4]. Inflammasomes are innate 
sensors in which apoptosis-associated speck-like protein containing a caspase 
recruitment domain (ASC) connects the sensing of microbial molecular patterns or 
cellular stress by NLRs to Caspase-1 (Casp-1)-mediated maturation of interleukin 
(IL-)-1β and IL-18 [5]. The results in the study using Casp-1 knockout mice have 
3 
 
strongly suggested that Casp-1 plays a key role in DSS-induced colitis [6]. The NLRP3 
inflammasome plays a key role in inflammation because disease-associated NLRP3 
mutations enhance Casp-1 activation and IL-1β production [7]. Furthermore, a 
decreased NLRP3 level and decreased IL-1β secretion were recently reported to be 
linked with increased susceptibility to CD in humans [8]. On the other hand, ASC-
dependent inflammasomes, such as NLRP6, were identified as a key immune axis 
regulating the intestinal microbiota [9]. The NLRP6 inflammasome has been shown to 
play critical roles in defense against infection, autoinflammation, and tumorigenesis. 
As NLRP6 is highly expressed in epithelial cells, especially goblet cells, this 
inflammasome has been considered an essential factor for mucosal self-renewal, cell 
proliferation, and regulation of intestinal flora through mucus secretion and anti-
microbial peptide production from goblet cells [10] and the epithelium [11]. 
The composition of the intestinal flora was associated with the pathogenesis of UC and 
CD. The gut microbiota influences the homeostasis of the intestinal mucosa via its 
barrier function [12]. Mucosal barrier integrity is essential to blocking the access of 
microorganisms to underlying tissues. Studies in a rodent model have linked tissue 
damage and the disruption of the epithelial barrier in the gut to cytokine imbalances 
[13]. UC is generally recognized as an immune-mediated disorder resulting from the 
abnormal interaction between intestinal microbiota and mucosal immune cells. 
Differential compositions of intestinal microbiota have been reported in patients with 
IBD [14]. The strictly anaerobic bacteria, Bacteroides spp. plays a vital role in the 
induction of colitis [15-18]. Bacterial content analysis shows that Bacteroides spp. is 
highly represented in patients with UC but are present in lower amounts in healthy 
adults [19]. Two bacteria species, Bifidobacterium spp. and the Clostridium perfringens 
group, are known as beneficial factors to UC [20-22]. 
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Current therapies for patients with IBD have limited efficacy and present potentially 
serious side-effects on long-term use [23]. Hence, along with the development of new 
drugs, supplements might represent, in combination, an important approach. Recently, 
natural plants containing polyphenols have attracted wide attention because 
polyphenols have anti-inflammatory properties. For example, grape pomace extracts 
depress colonic inflammation by preventing the expression of proinflammatory genes 
and regulating oxidative stress in colitis [24].  
We have focused on the mulberry, already used in traditional medicine, rich in 
beneficial ingredients such as polyphenols, especially anthocyanin [25-27]. The aim of 
this study was to determine the inhibitory effect of mulberry against UC and understand 
its mode of action in DSS-induced colitis in the mouse model.  
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Materials and Methods 
Diet preparation and reagents 
Mulberry used in this study was harvested in the Shiraishi Island of Okayama prefecture. 
The contents of anthocyanins, as major polyphenols in this fruit, were 80 mg/g of 
cyanidin-3-glucoside and 24 mg/g of cyanidin-3-rutinoside. Mulberry juice freeze-
dried powder (MFP) from the 5 x concentrated mulberry fruit juice kindly given by 
Okayamaken Seikabutsu Hanbai Co. Ltd (Okayama, Japan) was prepared in the freeze 
dryer (TD-81TA, Tokyo Rikakikai Co., Ltd., Tokyo, Japan). The anthocyanin content 
was 7 mg/g MFP. MFP was stored at -20˚C until use. MFP-containing diet was prepared 
as a mix with the normal diet (AIN93G: Oriental Yeast Co., Ltd., Tokyo, Japan). DSS 
5000 was purchased from Wako Pure Chemical Industries Co., Ltd. (Osaka, Japan).  
Animals and experimental design 
BALB/c mice (male, 7 weeks old) were purchased from Charles River Laboratories 
Japan, Inc (Osaka, Japan). The animals were housed at a constant temperature (22 ± 1 
˚C) with a 12-h dark/light cycle and had access to tap water and food. All procedures 
were approved by the Animal Care and Use Committee, Okayama University (OKU-
2017096) and were conducted in accordance with the Policy on the Care and Use of the 
Laboratory Animals, Okayama University.  
The experimental periods were 28 days in total. In the first 3 weeks, mice (7 weeks old) 
were randomly divided into 6 groups (n = 3) and were maintained on different diets or 
drinking water, as shown in Table 1. Briefly, the diet with (Group 1 to 4) or without 
(Group 5 and 6) MFP (final anthocyanin concentration: 50 mg/kg) was supplied daily 
for the first 3 weeks. Then, the mice in Groups 1, 3, and 5 were supplied drinking water 
containing 5% (w/v) DSS for 1 week; and body weight and fecal condition in mice were 
monitored daily. The mice in Groups 2, 4, and 6 were supplied with normal water. At 
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the same time, the mice (in Groups 1 and 2) received a fourth week supply of the diet 
with MFP. At the end of the experiment, all the mice were sacrificed, and their colonic 
tissues were collected, and lengths measured. The disease activity index (DAI) scores 
were calculated according to the fecal condition and body weight loss (Table 2) as 
described elsewhere [28]. Then, the colon was divided into three parts after tissue 
collection. The proximal part of colon was immediately frozen at -80˚C for gene 
expression analysis. Both middle and distal colon were fixed with 10% formaldehyde 
for histopathological observation. 
Histopathological examination 
The middle and distal regions were embedded in paraffin, sectioned at 5-μm thickness, 
and de-paraffinized.  Sectioned specimens were stained using a hematoxylin eosin (HE) 
solution. HE specimens were observed under the light microscope (Olympus FSX100, 
Olympus, Tokyo, Japan) to evaluate the tissue damage and to count the number of 
goblet cells (magnification, x200 and x400). The microscopic score was calculated 
according to the scoring system as described previously (Table 3) [29]. HE specimens 
(3 specimens/each region/mouse) were made, and then the number of goblet cells were 
counted in three fields of each specimen under the light microscope (magnification, x 
400). 
Gene expression analysis 
Total RNAs were extracted from colonic tissues in each mouse using the SV Total RNA 
Isolation System (Promega, Madison, WI) according to the manufacturer’s instructions. 
The concentration of RNA was quantified using SmartSpec plus Spectrophotometer 
(Bio-Rad Laboratories Inc., Tokyo, Japan). One microgram of total RNA was subjected 
to reverse transcription with oligo (dT18) primers using the First Strand cDNA synthesis 
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kit (Takara Biotechnology, Shiga, Japan) according to manufacturer’s instructions. All 
the cDNA preparations were stored at -20˚C until further use. 
The quantitative real-time polymerase chain reaction (qRT-PCR) was conducted in the 
Mini Opticon Real-Time PCR System (Bio-Rad Laboratories Inc.) using the Brilliant 
III Ultra-Fast SYBR® Green QPCR Master Mix Kit (Agilent Technologies, West Cedar 
Creek, TX). Expression values were normalized to GAPDH in the same sample and 
then normalized to the control. The sequences of the primer pairs used for qRT-PCR 
amplification are listed in Table 4. Samples were heated at 95˚C for 5 min and then 
subjected to 40 cycles of denaturation at 95˚C for 5 sec and annealing/elongation for 10 
sec at annealing/elongation temperatures described in Table 4. The amplifications were 
performed on three independent samples, with triplicate reactions carried out for each 
sample. The relative mRNA level was calculated using the 2−ΔΔCT method.  
Assessment of bacterial contents using qPCR 
Fecal DNA samples from mice in all the 6 groups were extracted using the QIAamp® 
DNA Stool Mini Kit (QIAGEN, Hilden, Germany) according to the manufacturer’s 
protocol. qPCR amplification and detection were performed in the Mini Opticon Real-
Time PCR System (Bio-Rad Laboratories Inc.) using the Brilliant III Ultra-Fast SYBR® 
Green QPCR Master Mix Kit (Agilent Technologies).  
To determine of the number of Bacteroides spp., Bifidobacterium spp., and C. 
perfringens subgroup present in each sample, fluorescent signals detected from serial 
dilutions in the linear range of the assay were averaged and compared to a standard 
curve generated with standard plasmid DNA in the same experiment. The primer pairs 
and qPCR conditions used were those described by Rinttilä et al. [30]. The resulting 
levels of total bacteria were assessed using a 16S specific primer pair (357f: 5’-
CTCCTACGGGAGGCAGCAG-3’ and 517r: (5’-ATTACCGCGGCTGC TGG-3’). 
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Samples were heated at 95˚C for 5 min and then subjected to 35 cycles of denaturation 
at 95˚C for 15 sec and annealing/elongation at 60˚C for 20 sec. The 16S rRNA 
sequences from each bacterial strain [Bacteroides fragilis (JCM 11019T), 
Bifidobacterium longum (JCM 1217T), C. perfringens (JCM 1290 T), and Escherichia 
coli (JCM 1649T)] were cloned. The plasmid inserted with the 16S rRNA sequence 
from each bacterial strain was used to define the standard curve. 
Statistical analysis 
Data were expressed as the mean ± standard error of the mean (SE) or the mean ± 
standard deviation (SD) of three independent experiments. Data were statistically 
evaluated by one-way analysis of variance followed by Tukey’s HSD using IBM SPSS 
Statistics software.  Values of p < 0.05 (*), p < 0.01 (**), and p < 0.001 (***) were 
considered statistically significant.  
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Results 
Body weight gain, colon length, and disease activity 
Prior to DSS administration, body weight did not differ among mice groups (data not 
shown). The body weight after DSS administration is shown in Fig. 1A. The body 
weight in mice of the DSS treatment groups (Groups 1, 3, and 5) was decreased after 
DSS administration. In Group 5 mice compared with Group 6 mice, the body weight 
gain was decreased by about 25%. The reduction in body weight in Group 1 mice was 
delayed by 2 days compared with that of Group 5 mice (weight decrease in Group 3 
mice occurred in the time intermediately). The colon length was significantly shortened 
in the DSS administration group without MFP (Group 5) (Fig. 1B). The DAI score 
increased gradually over the last 3 days in the DSS administration group (Fig. 1C). 
However, disease signs appeared later in the MFP-administered group (Group 1).  The 
DAI score in Group 1 mice was significantly lower than those in Group 3 and Group 5 
mice. Thus, MFP significantly attenuated the clinical symptoms of colitis (Fig. 1C). 
Histopathology 
Both middle and distal colon regions were observed for histopathological examination. 
In mice administered DSS, the colons showed a destruction of the epithelial layer and 
the infiltration of inflammatory cells, such as neutrophils, extending through the 
mucosa and sub-mucosa (Fig. 2A). MFP administration attenuated the extent and 
severity of lesions and improved the epithelium architecture. The histological scores 
were calculated according to these observations, with a lower score in Group 1 mice 
than in Group 5 mice (Fig. 2B). In Group 1, MFP administration allowed only a 
moderate inflammatory infiltration, indicating an important reduction of colon damage. 
The number of goblet cells in Group 1 epithelia was significantly higher than those in 
Groups 3 or 5 (Fig. 2C).  
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Gene expression analysis 
The expression of proinflammatory cytokines and NLRP3 was down-regulated by MFP 
administration (Fig. 3). The mRNA expression levels of IL-1β, tumor necrosis factor 
(TNF-)-α, and NLRP3 in Group 3 were higher than those in Group 1. Both NLRP6 and 
ASC in Group 1 seemed to be expressed at higher levels than those in Groups 3 or 5, 
but the differences were not statistically significant (G1 vs G3: p = 0.347; G1 vs G5: p 
= 0.163). 
Bacterial content analysis 
qPCR analyses were performed to quantity Bacteroides spp., Bifidobacterium spp., and 
C. perfringens subgroup in fecal samples (Fig. 4). The total bacterial population count 
was 109-10 copies/g in control fecal samples, and a significant decrease was observed in 
the total bacterial contents in Group 3 mice fecal samples. The decrease of the 
Bifidobacterium spp. copy number in both Group 3 and 5 mice was significant when 
compared with Group 1 mice (p < 0.05). A significant increase was observed for the 
Bacteroides spp. population in group 5 compared with Group 3 mice (p < 0.05). The C. 
perfringens subgroup population in Group 1 mice was much higher than that in both 
Groups 3 and 5 (p < 0.05). 
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Discussion 
IBD is a chronic pathology resulting from uncontrolled inflammation that ultimately 
leads to mucosal disruption and ulceration. Following epithelial barrier dysfunction, 
bacteria invade the mucosal layer, resulting in the activation of immune cells. In 
particular, macrophages play a key role in this disease pathogenesis because they 
release proinflammatory cytokines and ROS [31]. Indeed, the infiltration of a large 
number of macrophages is observed in the mucosa during active colitis [32]. ROS is an 
important factor in the mechanism of IBD pathogenesis. In the context of limited 
therapy options for patients with IBD, biological and clinical benefits, such as 
inflammation modulation, was recently reported for fruits, such as berries, containing 
anthocyanin. Anthocyanins are non-toxic water-soluble pigments with great anti-
oxidative capacity. Anthocyanins from blueberry and grape have proven to mitigate 
IBD symptoms [33]. In this study, we have focused on the mulberry fruit richer in 
anthocyanin content than other berries. Anthocyanins are major functional polyphenols 
in this fruit, probably explaining their use in China and Japan in traditional medicines 
against various diseases [34-39].  
The aim of this study was to determine the effect of mulberry against UC and on the 
mouse intestinal microbiota in DSS-induced colitis. Our results indicate that MFP 
reduces the major symptoms of DSS-induced acute colitis, including body weight loss, 
colon shortening, and colonic inflammation (Fig. 1). Feeding the mice, a MFP mixed 
diet modified the colonic microenvironment, which may play an important role in 
reducing DSS-induced colonic injury and inflammation and/or maintaining the gut 
barrier, as evidenced by the reduced DAI score and histological damage, and the 
increased goblet cell number. Moreover, few infiltrated immune cells were observed 
suggesting that MFP can protect the mucosal barrier and suppress the activation of 
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macrophages. Thus, the oral administration of MFP significantly mitigates the disease 
severity in DSS-induced acute colitis, suggesting that a daily supplement of MFP has 
health benefits. 
The NLRP3 inflammasome activation by ROS and/or danger signals, including 
pathogen-associated molecular patterns, results in the Casp-1-dependent processing of 
IL-1β and IL-18 [40]. IL-1β participates in the inflammation response, activating 
lymphocytes, and promoting immune cell infiltration at the site of injury and 
inflammation. Our data show that MFP reduces the mRNA expression of IL-1β and 
NLRP3 inflammasomes in mice fed MFP, suggesting that MFP acts as a powerful 
antioxidant and cancels the ROS influence in the colonic microenvironment.  
Our result of the increased expression of NLRP6 inflammasomes in mice fed MFP 
suggest a key role of NLRP6 in intestinal homeostasis by regulating IL-18 expression, 
secreting mucin, and producing anti-microbial peptides from goblet cells. The mucus 
overlying the epithelial cells is secreted mainly by goblet cells, and the secretion is 
regulated by NLRP6 inflammasomes [10]. Our results showed that goblet cells are 
maintained in Group 1 mice compared with Group 3 and 5 mice, suggesting that MFP 
promotes the formation of NLRP6 inflammasomes and preserves the goblet cell number. 
This might lead to protective mucus barrier in the colon, resulting in the inhibition of 
DSS-induced acute colitis. Moreover, NLRP6 inflammasomes can negatively regulate 
the NF-kB and MAPK signaling pathways to control the expression of proinflammatory 
cytokines [41]. NLRP6 inflammasome-deficient mice are characterized by the 
infiltration of inflammatory cells in the lamina propria and the exacerbation of colitis 
[42].  
Several studies have reported that the intestinal flora plays a key role in the pathogenesis 
of intestinal inflammation and that intestinal microbial dysbiosis is closely associated 
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with the pathogenesis of DSS-induced UC [43-46]. Animal models indicate that 
intestinal bacteria have different proinflammatory activities in relation to the induction 
of colitis. For instance, Bifidobacterium spp., a kind of probiotic, has an inhibitory 
effect on DSS-induced colitis [47,48]. Bacteroides spp. [18,49] and E. coli [18] are 
considered as two pathogenic bacteria for colitis. Clostridium spp. promote the 
accumulation of regulatory T cells, which play a key role in mucosal immunity [50]. 
Some Clostridium species are considered as pathogens, such as C. difficile [51]. On the 
other hand, C. butyricum, which belongs to C. perfringens group, is probiotic bacteria 
able to reduce intestinal inflammation by improving the mucosal barrier function and 
modulating immune responses [52]. In this study, we determined the contents of 
Bifidobacterium spp. and C. perfringens group; our results indicate that those two 
bacterial groups were significantly increased in mice fed MFP of Group 1 compared 
with Group 3 and Group 5 mice that were not fed MFP (Fig 4). As these probiotic 
bacteria reduce mucosal inflammation by modulating cytokine production, decreasing 
oxidative stress, and enhancing the mucosal barrier [21,53,54], our results suggest that 
MFP increases immunomodulation in the colon by the increased contents of these 
bacteria. 
In conclusion, MFP attenuates disease severity and provides mucosal protection by 
modifying the bacterial content, maintaining the goblet cells, and activating NLRP6 
inflammasomes in DSS-induced acute colitis. MFP contains the anthocyanins, 
cyanidin-3-glucoside and cyanidin-3-rutinoside as functional antioxidative ingredients. 
These findings suggest that MFP has beneficial health effects. 
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Tables with captions 
Table 1. The grouping of mice. 
Table 2. The scoring system for Disease activity index. 
Table 3. The scoring system for Histological damages. 
Table 4. The Primer sets for cytokine and NLRPs. 
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Figure legends 
Figure 1. MFP significantly attenuated the clinical symptoms of colitis. 
A Mulberry diet inhibits colon inflammation produced in DSS-induced colitis. During 
the 5% DSS-induced week, (A) daily weights were measured (n＝3/group) and 
calculated as a percentage of body weight change from the first day of the week. At the 
end of day 7, all the mice were sacrificed, and their colonic tissues were collected. *p 
< 0.05, **p < 0.01, ***p < 0.001. (B) The length of the colonic tissues was measured. 
(C) DAI scores were measured according to the fecal condition and body weight loss. 
All data are represented as the mean ± SD of three separate experiments and analyzed 
by a one-way ANOVA followed by Tukey’s HSD using IBM SPSS Statistics software. 
Different letters (a, b, and c) indicate significant differences between groups at p < 0.05. 
 
Figure 2. Histopathologic results shown by HE stains. 
At the end of the experiment, all the mice were sacrificed, and their colonic tissues were 
collected. (A) HE-stained specimens observed under light microscopy. The arrowheads 
indicate the infiltration of inflammatory cells. The arrows indicate the goblet cells. (B) 
The microscopic scores are indicated. The microscopic score was calculated according 
to the scoring system. (C) The number of goblet cells was measured. All data are 
represented as the mean ± SD of three separate experiments and analyzed by a one-way 
ANOVA followed by Tukey’s HSD using IBM SPSS Statistics software. MD 
Mulberry diet; ND Normal diet; w week; DSS dextran sodium sulfate; D day; G 
Group. Different letters (a, b, and c) indicate significant differences between groups at 
p < 0.05. 
 
Figure 3. mRNA expression levels of cytokines and NLRPs in colonic tissues. 
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At the end of the experiment, all the mice were sacrificed, and their colonic tissues were 
collected. mRNA expression levels of cytokines (IL-1β and TNF-α) and NLRPs 
(NLRP3, ASC, and NLRP6) in colonic tissues from the mice with/without MFP and 
DSS. All data are represented as the mean ± SE of three separate experiments and 
analyzed by a one-way ANOVA followed by Tukey’s HSD using IBM SPSS Statistics 
software. 
 
Figure 4. qPCR detection of total bacteria. 
The fecal samples for qPCR detection of bacteria were collected at the end of 
experiments. Fecal DNA samples from mice in all the 6 groups were extracted, and 
qRT-PCR amplification and detection were performed. Bacteroides spp., 
Bifidobacterium spp., and C. perfringens subgroup contents are presented as the 
bacterial copy number in fecal microbiota. Different letters (a, b, c, d, and e) indicate 
significant differences between groups at p < 0.05. All data are represented as the mean 
± SD of three separate experiments and analyzed by a one-way ANOVA followed by 
Tukey’s HSD using IBM SPSS Statistics software. 
